Dewen Mao
Overview
Explore the profile of Dewen Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie A, Soontornchai S, Bovornkitti S, Mao D, Shi Q, You J
J Eval Clin Pract
. 2025 Jan;
31(1):e14261.
PMID: 39831645
Rationale: Liver fibrosis is a critical stage in the progression from liver injury to cirrhosis or tumor formation. Traditional Chinese medicine (TCM) has shown certain effectiveness in treating liver fibrosis....
2.
Zhang P, Gan D, Chi X, Mao D, Gao Y, Li Y, et al.
Sci Rep
. 2024 Feb;
14(1):4005.
PMID: 38369632
Number connection test A (NCT-A) and digit symbol test (DST), the preferential neuropsychological tests to detect minimal hepatic encephalopathy (MHE) in China, haven't been standardized in Chinese population. We aimed...
3.
Yao C, Huang L, Wang M, Mao D, Wang M, Zheng J, et al.
Sci Rep
. 2023 Nov;
13(1):19544.
PMID: 37945916
To establish a high-quality, easy-to-use, and effective risk prediction model for hepatic encephalopathy, to help healthcare professionals with identifying people who are at high risk of getting hepatic encephalopathy, and...
4.
Lin Y, Yan G, Wang M, Zhang K, Shu F, Liu M, et al.
Open Life Sci
. 2023 Sep;
18(1):20220636.
PMID: 37724112
Liver failure is a common clinical syndrome of severe liver diseases, which belongs to one of the critical medical conditions. Immune response plays a leading role in the pathogenesis of...
5.
He W, Xu C, Mao D, Zheng Y, Wang N, Wang M, et al.
Phytother Res
. 2023 Aug;
37(12):5473-5494.
PMID: 37622684
In recent years, the incidence of liver disease has increased, becoming a major cause of death. Various liver diseases are intricately linked to pyroptosis, which is one of the most...
6.
Chen Y, Bai W, Mao D, Long F, Wang N, Wang K, et al.
Adv Clin Exp Med
. 2022 Nov;
32(4):407-414.
PMID: 36413178
Introduction: The prevalence of chronic kidney disease (CKD) rises with age and co-morbid diseases such as liver diseases. Objectives: The main aim of the current meta-analysis is to assess the...
7.
Ye Z, Huang Q, She Y, Hu Y, Wu M, Qin K, et al.
Front Med (Lausanne)
. 2022 Oct;
9:920062.
PMID: 36314011
Background: Hepatic fibrosis is a health challenge due to the absence of satisfactory therapy, especially at the cirrhosis stage. Dahuang Zhechong pill (DHZCP)-based therapy is reportedly a successful treatment for...
8.
Huang G, Xie S, Wang M, Mao D, Huang G, Huang J, et al.
Biomed Chromatogr
. 2022 Oct;
37(1):e5529.
PMID: 36250932
This study used gas chromatography-time-of-flight mass spectrometry (GC-TOFMS) and ultra-performance liquid chromatography-quadrupole TOFMS (UPLC-QTOFMS) metabonomic analytical techniques in combination with bioinformatics and pattern recognition analysis methods to analyze the serum...
9.
Zhang R, Zhong L, Sun K, Liu J, Wang Q, Mao D, et al.
Biomed Res Int
. 2022 Jun;
2022:9912776.
PMID: 35647179
Objective: To study the mechanism of curcumol affecting the proliferation and apoptosis of liver cancer cells through the DJ-1/PTEN/PI3K/AKT pathway. Method: HepG2 cells were cultured in vitro, treated with curcumol...
10.
Bai W, Shi Q, Wu J, Wang K, Chen Y, Ma X, et al.
Biomed Res Int
. 2022 May;
2022:4479885.
PMID: 35601154
Objective: To research the influence of Chinese medicine Jiedu Huayu granules (JDHY) on the immune response and inflammatory response of rats with acute liver failure (ALF) and investigate its related...